MediSim VR partners with Harvard simulation lab director to drive VR-based medical training globally

MediSim VR, a med tech company committed to designing the future of medical training, announced its association with a global industry expert, Dr Gianluca De Novi, to lead the penetration of VR-based education at the global level.

MediSim VR is the leading player in VR medical simulation training in India. "Their patented technology offers various training procedures for medical & nursing students in a fully virtual & safe environment," said the company in a statement.

MediSim VR combines the benefits of Virtual Reality (VR) and simulation to deliver immersive learning for skill training. Their built-in AI-based competency assessment tool provides comprehensive performance metrics to both students & the institution, it said.


The Global VR healthcare market is projected to reach $30.40 billion by 2026, exhibiting a CAGR of 42.4%. The Indian market size is expected to reach $1.2 billion.

The MediSim VR's immediate focus will be geared mainly towards Skill training, education, surgery, patient care management and therapy procedures.

VR also has a tremendous calming effect on patients with terminal illnesses or traumatic accident injuries patients, such as war injury, etc. as a treatment procedure as it can give them a simulated happy ending, which helps to have a calming effect and thus have a huge potential even in treatment beyond simulating medical learning for enhancement of better training of medical or healthcare staff in India.

Dr. Gianluca De Novi, Director of the Harvard simulation lab, is a pioneer and world-leading medical simulation expert. Their engagement will reinforce MediSim VR’s commitment at a global level to drive VR simulation-based training for medical students.